The i-Thymus: wielding the potential of gene therapy, cell therapy and induced pluripotent stem cells for the regeneration of the thymus and the adaptive immune system

Project Information

i-THYMUS

Grant agreement ID: 190124491

DOI

10.3030/190124491

EC signature date 17 November 2023

Start date 1 November 2023

End date 31 October 2025

Funded under

• The European Innovation Council (EIC)

Total cost

€ 3 565 015,61

EU contribution

€ 2 495 510,93

Coordinated by

GENEWITY BV
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Intellectual Property Rights

Patent (1)

METHODS FOR GENERATING ARTIFICIAL THYMUS, PRODUCTS AND USES THEREOF

Application/Publication number: 20 24057477
Date: 2024-03-20
Applicant(s): GENEWITY BV

Trademark (2)

Genewity

Application/Publication number: . Genewity
Date: 2024-05-13
Applicant(s): GENEWITY BV

i-Thymus

Application/Publication number: i- Thymus
Date: 2024-05-13
Applicant(s): GENEWITY BV